BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2225552)

  • 1. Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: value of quantitative scoring and approach to final prognosis.
    Alamartine E; Sabatier JC; Berthoux FC
    Clin Nephrol; 1990 Aug; 34(2):45-51. PubMed ID: 2225552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
    Magil AB; Ballon HS; Chan V; Lirenman DS; Rae A; Sutton RA
    Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA nephropathy in Korea: a morphological and clinical study.
    Lee HS; Koh HI; Lee HB; Park HC
    Clin Nephrol; 1987 Mar; 27(3):131-40. PubMed ID: 3552343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature.
    Ibels LS; Györy AZ
    Medicine (Baltimore); 1994 Mar; 73(2):79-102. PubMed ID: 8152367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.
    Ikee R; Kobayashi S; Saigusa T; Namikoshi T; Yamada M; Hemmi N; Imakiire T; Kikuchi Y; Suzuki S; Miura S
    Hypertens Res; 2006 Jan; 29(1):15-22. PubMed ID: 16715649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary IgA mesangial nephropathy (Berger's disease): clinico-pathological study].
    Nussenzveig I; Saldanha LB; Marcondes M
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(1):7-20. PubMed ID: 2814190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of extracapillary lesions (ECL) in progression of IgA nephropathy.
    Abe T; Kida H; Yoshimura M; Yokoyama H; Koshino Y; Tomosugi N; Hattori N
    Clin Nephrol; 1986 Jan; 25(1):37-41. PubMed ID: 3955907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative analysis of the mesangium in children with IgA nephropathy: sequential study.
    Suzuki J; Yoshikawa N; Nakamura H
    J Pathol; 1990 May; 161(1):57-64. PubMed ID: 2370599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berger's disease in children. Natural history and outcome.
    Lévy M; Gonzalez-Burchard G; Broyer M; Dommergues JP; Foulard M; Sorez JP; Habib R
    Medicine (Baltimore); 1985 May; 64(3):157-80. PubMed ID: 3887094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients.
    D'Amico G; Imbasciati E; Barbiano Di Belgioioso G; Bertoli S; Fogazzi G; Ferrario F; Fellin G; Ragni A; Colasanti G; Minetti L
    Medicine (Baltimore); 1985 Jan; 64(1):49-60. PubMed ID: 3880853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myofibroblasts, predictors of progression of mesangial IgA nephropathy?
    Goumenos DS; Brown CB; Shortland J; el Nahas AM
    Nephrol Dial Transplant; 1994; 9(10):1418-25. PubMed ID: 7816254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Semiquantitative histological evaluation of IgA nephropathy and Cox's proportional Hazzard model analysis].
    Nakao N
    Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1063-70. PubMed ID: 1808358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IgA nephropathy--analysis of 60 cases].
    Danilewicz M; Wagrowska-Danilewicz M
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):141-3. PubMed ID: 8090667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and natural history of IgA nephropathy.
    Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
    Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
    Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
    Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
    Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.